Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul 24:6:53-61.
doi: 10.2147/TACG.S35605. Print 2013.

Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors

D Gareth R Evans  1 , Sarah Louise Ingham
Affiliations

Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors

D Gareth R Evans et al. Appl Clin Genet. .

Abstract

There are several hereditary diseases that are a predisposition to early-onset tumors. These include syndromic conditions like neurofibromatosis 1 and 2, von Hippel-Lindau syndrome, Gorlin syndrome, multiple endocrine neoplasia, and familial adenomatous polyposis; and conditions which are usually not possible to diagnose clinically in a single individual, such as Lynch syndrome and BRCA1/2. Understanding of the mortality in hereditary cancer predisposing diseases is important for developing effective disease treatment programs. A number of studies have been undertaken to investigate the genetic predictors, prevalence and incidence, and treatment outcomes of these diseases; however, the majority examine only the most common of these diseases (eg, neurofibromatosis or BRCA), or look into postoperative survival. The mortality of individuals who are diagnosed with one of these hereditary diseases remains an area for investigation. This review is the first to attempt identification of studies investigating life expectancy in hereditary diseases which predispose to early-onset tumors.

Keywords: early-onset; life expectancy; mortality; survival; tumors.

PubMed Disclaimer

References

    1. Wilding A, Ingham SL, Lalloo F, et al. Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet. 2012;49(4):264–269. - PubMed
    1. Evans DG, O’Hara C, Wilding A, et al. Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet. 2011;19(11):1187–1191. - PMC - PubMed
    1. Pinson S.Neurofibromatosis type 1 or von Recklinghausen’s disease Paris: Orphanet Encyclopedia; 2002Available from: https://www.orpha.net/data/patho/Pro/en/Neurofibromatosis1-FRenPro185.pdfAccessed July 4, 2013
    1. Duong TA, Sbidian E, Valeyrie-Allanore L, et al. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980–2006 in France. Orphanet J Rare Dis. 2011;6:18. - PMC - PubMed
    1. Masocco M, Kodra Y, Vichi M, et al. Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995–2006) Orphanet J Rare Dis. 2011;6:11. - PMC - PubMed